Bold Vision.
Innovation at its best.

For almost 30 years, ProPhase has been relentlessly focused on enhancing wellness and improving health. Historically, we have been a diversified medical science and technology company that delivers breakthrough, clinically shown supplements, and OTC manufacturing. In 2020, we pivoted to build out state-of-the-art CLIA labs for COVID-19 diagnostic testing. In 2021, we acquired Nebula Genomics and formed ProPhase Precision Medicine. We are rapidly developing into a true diagnostics and genomics company that will leverage our CLIA laboratories for COVID-19 Testing, whole genome sequencing, and a wide variety of diagnostic testing. In 2022, we formed ProPhase BioPharma to license, develop and commercialize drugs and compounds with enormous potential. Our first licensing efforts included Equivir (OTC) and Equivir G (Rx), broad-based anti-viral compounds. We then licensed Linebacker 1 and 2, compounds that have multi-billion dollar potential as cancer co-therapies.

Lab Processing

Diagnostic Labs

  • Highly accurate COVID-19 PCR testing in our two state-of-the-art CLIA laboratories.
  • Also offering our best-in-class rapid antigen and antibody testing.
  • Next goal: A fully integrated Diagnostic Laboratory service with a complete clinical lab offering.
Learn More


  • The Nebula Whole Genome Sequencing test decodes 100% of the genome and provides up to 5,000x more data than other well-known consumer genetic tests.
  • This extremely accurate DNA test provides information on genetic mutations and examines your ancestry, health, diet and physical activity.
  • Nebula provides an online report with weekly updates to help our customers stay informed about the newest genetic insights and how this relates to a customer’s personal genetic makeup.
Learn More
Contract Manufacturing

Contract Manufacturing

  • 30+ years of OTC manufacturing services and consumer healthcare product development for contract and private label customers.
  • Capabilities range from non-GMO, Organic and/or Natural-based cough drops and lozenges for over-the-counter drug to dietary supplement products.
Learn More

Dietary Supplements

  • Line of consumer products that promote better health, energy, and sexual vitality.
  • Featuring formulas with clinical studies to back important claims.
  • Available online and in major Food Drug and Mass retail stores including Walmart, Walgreens, CVS, Rite-Aid and more.
Learn More

Next Goals

ProPhase Precision Medicine

Developing cutting-edge technologies in genomics testing to predict disease risk, characterize genetic mutations, and identify inherited disorders and drug responses, including those that drive cancer progression.

ProPhase BioPharma

Announced in June 2022 the formation of wholly-owned subsidiary ProPhase BioPharma, Inc. (PBIO) for the licensing and development of novel drugs, compounds, and biotechnology.

Press Releases

See our latest innovations and breaking news

Sep 06 2022 8:15AM ET

ProPhase Labs to Present at the H.C. Wainwright 24th Annual Global Investment Conference September 12-14, 2022 (HYBRID CONFERENCE)

Read More

Aug 11 2022 8:00AM ET

ProPhase Labs Announces Record Second Quarter 2022 Financial Results

Read More

Aug 04 2022 8:33PM ET

ProPhase Labs to Host Second Quarter 2022 Financial Results Conference Call on Thursday, August 11, 2022 at 11:00 a.m. Eastern Time

Read More
Investor Relations

Get In Touch

We care about your questions and will be in touch usually within 24 hours

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Dev Tool:

Request: None
Matched Rewrite Rule: None
Matched Rewrite Query: None
Loaded Template: front-page.php